These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. A cluster of VanD vancomycin-resistant Enterococcus faecium: molecular characterization and clinical epidemiology. Ostrowsky BE, Clark NC, Thauvin-Eliopoulos C, Venkataraman L, Samore MH, Tenover FC, Eliopoulos GM, Moellering RC, Gold HS. J Infect Dis; 1999 Oct; 180(4):1177-85. PubMed ID: 10479146 [Abstract] [Full Text] [Related]
9. New combinations of mutations in VanD-Type vancomycin-resistant Enterococcus faecium, Enterococcus faecalis, and Enterococcus avium strains. Depardieu F, Foucault ML, Bell J, Dubouix A, Guibert M, Lavigne JP, Levast M, Courvalin P. Antimicrob Agents Chemother; 2009 May; 53(5):1952-63. PubMed ID: 19258279 [Abstract] [Full Text] [Related]
10. Characterization of a divergent vanD-type resistance element from the first glycopeptide-resistant strain of Enterococcus faecium isolated in Brazil. Dalla Costa LM, Reynolds PE, Souza HA, Souza DC, Palepou MF, Woodford N. Antimicrob Agents Chemother; 2000 Dec; 44(12):3444-6. PubMed ID: 11083656 [Abstract] [Full Text] [Related]
12. A six amino acid deletion, partially overlapping the VanSB G2 ATP-binding motif, leads to constitutive glycopeptide resistance in VanB-type Enterococcus faecium. Depardieu F, Courvalin P, Msadek T. Mol Microbiol; 2003 Nov; 50(3):1069-83. PubMed ID: 14617162 [Abstract] [Full Text] [Related]
13. Influence of VanD type resistance on activities of glycopeptides in vitro and in experimental endocarditis due to Enterococcus faecium. Lefort A, Garry L, Depardieu F, Courvalin P, Fantin B. Antimicrob Agents Chemother; 2003 Nov; 47(11):3515-8. PubMed ID: 14576110 [Abstract] [Full Text] [Related]